Home › Funds › Royce & Associates › USPH
Royce & Associates position in USPH
U S PHYSICAL THERAPY · Health Care
Latest position (Q2 2024)62.30K sh
Reported value held$5.76M
Portfolio Weight0.05%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 3.60K | $398.00K | New |
| Q4 2021 | 5.89K | $563.00K | Add |
| Q1 2022 | 42.91K | $4.27M | Add |
| Q2 2022 | 45.07K | $4.92M | Add |
| Q3 2022 | 44.86K | $3.41M | Hold |
| Q4 2022 | 46.27K | $3.75K | Add |
| Q1 2023 | 42.44K | $4.16K | Reduce |
| Q2 2023 | 62.30K | $7.56M | Add |
| Q3 2023 | 62.30K | $5.71M | Hold |
| Q4 2023 | 62.30K | $5.80M | Hold |
| Q1 2024 | 62.30K | $7.03M | Hold |
| Q2 2024 | 62.30K | $5.76M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding USPH
- BlackRock Inc 2.26M sh · $155.51M · Q2 2026
- Vanguard Group 1.09M sh · $84.75M · Q4 2025
- Morgan Stanley 698.69K sh · $47.99M · Q2 2026
- Geode Capital Management 385.73K sh · $26.50M · Q2 2026
- Bank of America Corp 282.19K sh · $19.38M · Q2 2026
- Northern Trust Corp 230.94K sh · $15.86M · Q2 2026
- Fidelity Management & Research (FMR) 143.23K sh · $9.84M · Q2 2026
- Charles Schwab Investment Management 137.13K sh · $9.42M · Q2 2026
- BNY Mellon 132.31K sh · $9.09M · Q2 2026
- Wells Fargo & Co 117.55K sh · $8.07M · Q2 2026
- Two Sigma Investments 110.58K sh · $7.59M · Q2 2026
- Principal Global Investors 94.72K sh · $6.51M · Q2 2026